Home > Category > Signaling Pathways > Immunology & Inflammation > CD markers > Theralizumab | TGN1412 | TAB-08 | TABO8

Theralizumab | TGN1412 | TAB-08 | TABO8

Catalog No:CLA1681 CAS No.:906068-56-2 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $719.00 Visible after login
- +
5 mg 3-5days $1880.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Theralizumab | TGN1412 | TAB-08 | TABO8
CAS906068-56-2
Storage condition store at -20°C | Shipping with blue ice.
Product details

Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis.


Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays